PATENT CLAIM ANALYSIS

Application Number: 16001549
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "047000"]

Abstract:
A compound of the structure: or a pharmaceutically acceptable salt or composition thereof for the treatment of a host infected with or exposed to an HCV virus or other disorders more fully described herein.

Claim (Index 6):
The method of  claim 1 , wherein the host is a human.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 94.0
- Lexical Diversity: 1.2
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15782628', '15782638', '15063461', '15645701', '15885630']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8265673437955158
- 35 USC 102 Novelty (BERT): 0.5888755782684818
- Combined Prediction Score: 0.8027981672428124
- Mean Citation Score: 366.46165
- Max Citation Score: 453.97845
- Similarity Product: 293.866314202559

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test